Vietnam MOH registration 50318
Biomatrix Alpha Drug Eluting Coronary Stent System
VN: Hệ stent mạch vành giải phóng thuốc Biomatrix Alpha ( Biomatrix Alpha Drug Eluting Coronary Stent System)
Hệ stent mạch vành giải phóng thuốc Biomatrix Alpha
Vietnam·Biomatrix Alpha Drug Eluting Coronary Stent System·Biosensors Interventional Technologies Pte. Ltd.·Registered Apr 06, 2022 – Apr 01, 2024ExpiredRegistration details
- Analysis ID
- 50318
- Product Type
- Biomatrix Alpha Drug Eluting Coronary Stent System
Company information
- Manufacturer
- Biosensors Interventional Technologies Pte. Ltd.
- Manufacturer Country
- Singapore
- Product Owner
- Biosensors Europe SA
- Owner Country
- Switzerland
- Authorized Representative
- CPC1 Central Pharmaceutical Joint Stock Company
Technical details
- Unit
- Cái
Dates and status
- Registration Date
- Apr 06, 2022
- Expiry Date
- Apr 01, 2024
- Status
- Còn hiệu lực
Pricing
- Maximum Selling Price
- 46200000 VND
About this record
Access comprehensive regulatory information for Biomatrix Alpha Drug Eluting Coronary Stent System in Vietnam's medical device market through Pure Global AI's free database. is registered under number 50318 and manufactured by Biosensors Interventional Technologies Pte. Ltd.. The authorized representative in Vietnam is CPC1 Central Pharmaceutical Joint Stock Company.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI300,000+ Devices